Pharma Stability: Insights, Guidelines, and Expertise
Humidity control is especially critical for oral solid dosage forms (OSDFs), lyophilized products, and powders for reconstitution. Hygroscopic materials can absorb moisture, leading to:
Click to read the full article.
Intermediate stability studies are not just fallback tests—they provide essential insight into how products behave under modest stress. These studies serve to:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Combination products are regulated entities that consist of two or more components combined to achieve therapeutic or diagnostic functionality. These include:
Click to read the full article.
Packaging material is in constant contact with the pharmaceutical product, especially for oral liquids, injectables, and inhalers. Over time, this can lead to:
Click to read the full article.
Stability data validate the shelf life, quality, and safety of a drug product over time. Regulatory agencies expect real-time data under labeled storage conditions for decision-making.
Click to read the full article.
Stability studies involve multiple interconnected costs—from equipment and chambers to analytical testing and regulatory documentation. Without detailed financial forecasting, companies may face:
Click to read the full article.
Modified release formulations present unique stability concerns:
Click to read the full article.
Photostability cannot be treated as a separate concern from real-time stability. Several degradation mechanisms (e.g., photooxidation) require both thermal and photic input to be fully understood.
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.